Stock Analysis

Gulf Medical Projects Company (PJSC)'s (ADX:GMPC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

ADX:GMPC
Source: Shutterstock

Gulf Medical Projects Company (PJSC) (ADX:GMPC) has had a great run on the share market with its stock up by a significant 10.0% over the last week. However, we decided to pay close attention to its weak financials as we are doubtful that the current momentum will keep up, given the scenario. In this article, we decided to focus on Gulf Medical Projects Company (PJSC)'s ROE.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.

View our latest analysis for Gulf Medical Projects Company (PJSC)

How Do You Calculate Return On Equity?

The formula for ROE is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Gulf Medical Projects Company (PJSC) is:

6.4% = د.إ75m ÷ د.إ1.2b (Based on the trailing twelve months to December 2023).

The 'return' is the amount earned after tax over the last twelve months. Another way to think of that is that for every AED1 worth of equity, the company was able to earn AED0.06 in profit.

What Is The Relationship Between ROE And Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

Gulf Medical Projects Company (PJSC)'s Earnings Growth And 6.4% ROE

As you can see, Gulf Medical Projects Company (PJSC)'s ROE looks pretty weak. Even compared to the average industry ROE of 10%, the company's ROE is quite dismal. Given the circumstances, the significant decline in net income by 25% seen by Gulf Medical Projects Company (PJSC) over the last five years is not surprising. However, there could also be other factors causing the earnings to decline. Such as - low earnings retention or poor allocation of capital.

That being said, we compared Gulf Medical Projects Company (PJSC)'s performance with the industry and were concerned when we found that while the company has shrunk its earnings, the industry has grown its earnings at a rate of 15% in the same 5-year period.

past-earnings-growth
ADX:GMPC Past Earnings Growth May 2nd 2024

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Gulf Medical Projects Company (PJSC) is trading on a high P/E or a low P/E, relative to its industry.

Is Gulf Medical Projects Company (PJSC) Making Efficient Use Of Its Profits?

Gulf Medical Projects Company (PJSC)'s very high three-year median payout ratio of 193% over the last three years suggests that the company is paying its shareholders more than what it is earning and this explains the company's shrinking earnings. Paying a dividend higher than reported profits is not a sustainable move. Our risks dashboard should have the 3 risks we have identified for Gulf Medical Projects Company (PJSC).

In addition, Gulf Medical Projects Company (PJSC) has been paying dividends over a period of at least ten years suggesting that keeping up dividend payments is way more important to the management even if it comes at the cost of business growth.

Summary

In total, we would have a hard think before deciding on any investment action concerning Gulf Medical Projects Company (PJSC). The low ROE, combined with the fact that the company is paying out almost if not all, of its profits as dividends, has resulted in the lack or absence of growth in its earnings. Up till now, we've only made a short study of the company's growth data. You can do your own research on Gulf Medical Projects Company (PJSC) and see how it has performed in the past by looking at this FREE detailed graph of past earnings, revenue and cash flows.

Valuation is complex, but we're helping make it simple.

Find out whether Gulf Medical Projects Company (PJSC) is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.